Cargando…

Adrenomedullin Therapy in Patients with Refractory Ulcerative Colitis: A Case Series

BACKGROUND AND AIMS: Adrenomedullin (AM) is a multifunctional biologically active peptide that has an ameliorative effect against inflammatory bowel disease in several experimental models. We reported the first case where AM infusion dramatically improved symptoms and colonoscopy findings in patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ashizuka, Shinya, Inatsu, Haruhiko, Kita, Toshihiro, Kitamura, Kazuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761007/ https://www.ncbi.nlm.nih.gov/pubmed/26470867 http://dx.doi.org/10.1007/s10620-015-3917-0

Ejemplares similares

Adrenomedullin: A Novel Therapeutic for the Treatment of Inflammatory Bowel Disease
por: Ashizuka, Shinya, et al.
Publicado: (2021)

Adrenomedullin: A Novel Therapy for Intractable Crohn's Disease with a Loss of Response to Infliximab
por: Ashizuka, Shinya, et al.
Publicado: (2019)

Adrenomedullin for steroid-resistant ulcerative colitis: a randomized, double-blind, placebo-controlled phase-2a clinical trial
por: Kita, Toshihiro, et al.
Publicado: (2020)

Adrenomedullin Therapy in Moderate to Severe COVID-19
por: Kita, Toshihiro, et al.
Publicado: (2022)

Adrenomedullin for biologic‐resistant Crohn's disease: A randomized, double‐blind, placebo‐controlled phase 2a clinical trial
por: Kita, Toshihiro, et al.
Publicado: (2022)

Translational studies of adrenomedullin and related peptides regarding cardiovascular diseases
por: Kita, Toshihiro, et al.
Publicado: (2022)

Safety, Tolerability, and Pharmacokinetics of Adrenomedullin in Healthy Males: A Randomized, Double-Blind, Phase 1 Clinical Trial
por: Kita, Toshihiro, et al.
Publicado: (2020)

Refractory Duodenal Bleeding Ulcers Successfully Treated with Factor XIII Transfusion
por: Yamada, Yusuke, et al.
Publicado: (2021)

Primary Cardiac Leiomyosarcoma: A 27-Month Survival with Surgery and Chemotherapy
por: Nakashima, Koji, et al.
Publicado: (2017)

Adrenomedullin alleviates mucosal injury in experimental colitis and increases claudin‐4 expression in the colonic epithelium
por: Kawaguchi, Makiko, et al.
Publicado: (2023)

Salvage photodynamic therapy accompanied by extended lymphadenectomy for advanced esophageal carcinoma: A case report
por: Nishida, Takahiro, et al.
Publicado: (2017)

Development of Long-Acting Human Adrenomedullin Fc-Fusion Proteins
por: Nagata, Sayaka, et al.
Publicado: (2022)

Effectiveness of Concomitant Enteral Nutrition Therapy and Infliximab for Maintenance Treatment of Crohn’s Disease in Adults
por: Hirai, Fumihito, et al.
Publicado: (2012)

Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for Sepsis
por: Geven, Christopher, et al.
Publicado: (2018)

Efficacy of Indigo Naturalis Therapy for Ulcerative Colitis: A Case Series
por: Urushikubo, Jun, et al.
Publicado: (2019)

Hyperbaric oxygen therapy stimulates colonic stem cells and induces mucosal healing in patients with refractory ulcerative colitis: a prospective case series
por: Bekheit, Mohamed, et al.
Publicado: (2016)

Sacral neuromodulation for refractory ulcerative colitis: safety and efficacy in a prospective observational series of eight patients
por: Drissi, Farouk, et al.
Publicado: (2023)

Effect of a concomitant elemental diet with maintenance anti‐tumor necrosis factor‐α antibody therapy in patients with Crohn's disease: A multicenter, prospective cohort study
por: Hirai, Fumihito, et al.
Publicado: (2018)

Infliximab Induction Strategies in Corticosteroid-Refractory Acute Severe Ulcerative Colitis: A Case Series and Literature Review
por: Antunes, Pedro Bernardes, et al.
Publicado: (2022)

Effectiveness and Durability of Ustekinumab Therapy With or Without Immunomodulators for Ulcerative Colitis Patients in Japan
por: Aoki, Yasuhiro, et al.
Publicado: (2022)

Single Rectal Neuroendocrine Tumor Associated with Multiple Endocrine Cell Micronests
por: Suzuki, Sho, et al.
Publicado: (2019)

Rapid prediction of 1-year efficacy of tofacitinib for treating refractory ulcerative colitis
por: Shimizu, Hiromichi, et al.
Publicado: (2021)

Fecal microbiota transplantation in refractory ulcerative colitis – a case report
por: Moutinho, B. D., et al.
Publicado: (2019)

Esophageal Ulcers Associated with Ulcerative Colitis: A Case Series and Literature Review
por: Tominaga, Kentaro, et al.
Publicado: (2020)

Treatment-refractory ulcerative colitis responsive to indigo naturalis
por: Saiki, Julie P, et al.
Publicado: (2021)

Refractory Fulminant Colitis Requiring Surgical Intervention in a Patient With Ulcerative Colitis on Atezolizumab Therapy for Small Cell Lung Cancer: An Atypical Case
por: Steiger, Stephanie, et al.
Publicado: (2022)

Successful cyclosporin and ustekinumab combination therapy in a patient with severe steroid-refractory ulcerative colitis
por: Ganzleben, Ingo, et al.
Publicado: (2020)

Therapeutic efficacy of intra-articular adrenomedullin injection in antigen-induced arthritis in rabbits
por: Okura, Toshiyuki, et al.
Publicado: (2008)

Importance of eosinophilic infiltration of the colonic mucosa in ulcerative colitis patients who are refractory to maintenance therapy: A prospective, single-center study
por: Miyazu, Takahiro, et al.
Publicado: (2022)

Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
por: Xie, Feng, et al.
Publicado: (2009)

Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis
por: Pugliese, Daniela, et al.
Publicado: (2016)

Alicaforsen: An Emerging Therapeutic Agent for Ulcerative Colitis and Refractory Pouchitis
por: Hosten, Terron Anthony, et al.
Publicado: (2014)

Rapid Induction and Maintenance of Remission in Refractory Ulcerative Colitis with Ustekinumab
por: Chen, An-Yu, et al.
Publicado: (2019)

Combination Therapy With Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis
por: Tanida, Satoshi, et al.
Publicado: (2015)

Combination Therapy With Ustekinumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis
por: Tanida, Satoshi, et al.
Publicado: (2021)

Gender-related alterations in plasma adrenomedullin level and its correlation with body weight gain
por: Kawano, Sayaka, et al.
Publicado: (2015)

Use of corticosteroids for remission induction therapy in patients with new-onset ulcerative colitis in real-world settings
por: Okayasu, Motohiro, et al.
Publicado: (2019)

Fecal Microbiota Transplantation to Patients with Refractory Very Early Onset Ulcerative Colitis
por: Yodoshi, Toshifumi, et al.
Publicado: (2018)

Refractory Ulcerative Colitis Improved by Scheduled Combination Therapy of Vedolizumab and Granulocyte and Monocyte Adsorptive Apheresis
por: Nakamura, Masanao, et al.
Publicado: (2020)

Lack of Adrenomedullin Aggravates Acute TNBS-Induced Colitis Symptoms in Mice, Especially in Females
por: Martínez-Herrero, Sonia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_68h48d11ttg8tv1nmb8qo7rafe